Behavioral Health Business July 8, 2024
Primary care providers have increasingly offered patients medications for opioid use disorder (MOUD) since the Drug Addiction Treatment Act (DATA) of 2000 allowed certain physicians outside of the psychiatry field to prescribe these medications.
Low-barrier access to MOUDs, including naltrexone and buprenorphine, can play a meaningful role in combating the opioid use epidemic, which resulted in almost 82,000 deaths in 2022, according to the National Institute on Drug Abuse.
But most people either do not know that primary care physicians can prescribe MOUDs or incorrectly believe that these physicians cannot prescribe these medications, a new study funded by the National Institutes of Health (NIH) and published in JAMA Network Open found.
“The findings suggest most respondents did not know...
Today's Sponsors
Today's Sponsor